To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:230 Issue:2 Number:2 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
RCT
ACE Report #14551
Ace Report Cover Shoulder & Elbow

AAOS 2022: Buccally Absorbed Cannabidiol for Pain After Arthroscopic Rotator Cuff Repair


How to Cite

OrthoEvidence. AAOS 2022: Buccally Absorbed Cannabidiol for Pain After Arthroscopic Rotator Cuff Repair. ACE Report. 2022;230(2):2. Available from: https://myorthoevidence.com/AceReport/Report/14551

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Buccally Absorbed Cannabidiol Shows Promise in Treating Pain and Improving Satisfaction Immediately Following Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, DoubleBlinded, Randomized Trial

Contributing Authors:
MJ Alaia E Hurley LM Jazrawi G Gonzalez-Lomas DH Markus B Britton K Vasavada AS Rokito K Kaplan

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

100 patients undergoing arthroscopic rotator cuff repair were randomized to receive 14 days of oral, buccally absorbed cannabidiol (CBD; 25mg [<80kg] or 50mg [>80kg], three times per day) or placebo. Outcomes of interest included Visual Analog Scale (VAS) for pain, opioid consumption, satisfaction with pain control, liver function, and nausea, assessed up to 14 days follow up. Cannabidiol result i...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.